MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,818.93
+0.58%
NASDAQ 100
$31,224.47
+0.48%
DOW JONES
$51,521.00
+0.49%
NASDAQ Composite
$27,599.79
+0.45%
RUSSELL 2000
$2,813.40
-0.72%
CBOE VIX
$15.01
-3.29%

Sector Heatmap

Technology+0.53%
Financials+0.24%
Healthcare-0.17%
Consumer Cycl+1.20%
Consumer Staples+0.90%
Energy+0.47%
Industrials+0.87%
Materials+0.46%
Real Estate+1.06%
Utilities+2.98%
Comm Services+0.04%

MRK — Merck & Co., Inc.

NYSE

Merck & Co., Inc.

CompareBack to Screener
$141.94
+2.40(+1.72%)
O
140.13
H
142.16
L
139.74
V
8.05M
⏱️ End-of-day dataAs of Oct 6, 2026

Chart

About MRK

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. In cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 53% of the company's 2025 sales were generated from US human health (pharmaceuticals and vaccines).

IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateApr 20, 1949
Employees75,000
Stock ExchangeNYSE
Ticker SymbolMRK

Key Financial Statistics

Market Cap$356.01B
P/E RatioN/A
Dividend Yield2.40% (Quarterly)
EPSN/A
BetaN/A
52-Week Range$82.01 - $156.92
52-Week Avg Volume11.24M
VWAP$141.34
Transactions101,984
Total Recorded Bars14,311 days